201 related articles for article (PubMed ID: 23824659)
1. Galectin-4 Reduces Migration and Metastasis Formation of Pancreatic Cancer Cells.
Belo AI; van der Sar AM; Tefsen B; van Die I
PLoS One; 2013; 8(6):e65957. PubMed ID: 23824659
[TBL] [Abstract][Full Text] [Related]
2. Integrin alpha6beta1 role in metastatic behavior of human pancreatic carcinoma cells.
Vogelmann R; Kreuser ED; Adler G; Lutz MP
Int J Cancer; 1999 Mar; 80(5):791-5. PubMed ID: 10048983
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma.
Elsässer HP; Lehr U; Agricola B; Kern HF
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 61(5):295-306. PubMed ID: 1348891
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of CD9 promotes pancreatic cancer growth and metastasis through upregulation of epidermal growth factor on the cell surface.
Tang M; Yin G; Wang F; Liu H; Zhou S; Ni J; Chen C; Zhou Y; Zhao Y
Oncol Rep; 2015 Jul; 34(1):350-8. PubMed ID: 25955689
[TBL] [Abstract][Full Text] [Related]
5. Differential
Zhang T; van Die I; Tefsen B; van Vliet SJ; Laan LC; Zhang J; Ten Dijke P; Wuhrer M; Belo AI
Front Oncol; 2020; 10():732. PubMed ID: 32582529
[TBL] [Abstract][Full Text] [Related]
6. Staurosporine induces apoptosis in pancreatic carcinoma cells PaTu 8988t and Panc-1 via the intrinsic signaling pathway.
Malsy M; Bitzinger D; Graf B; Bundscherer A
Eur J Med Res; 2019 Jan; 24(1):5. PubMed ID: 30686270
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of cellular galectin-3 reveals no consistent oncogenic function in pancreatic cancer cells.
Hann A; Gruner A; Chen Y; Gress TM; Buchholz M
PLoS One; 2011; 6(6):e20859. PubMed ID: 21698183
[TBL] [Abstract][Full Text] [Related]
8. Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin.
Kobayashi T; Shimura T; Yajima T; Kubo N; Araki K; Tsutsumi S; Suzuki H; Kuwano H; Raz A
Int J Cancer; 2011 Dec; 129(12):2775-86. PubMed ID: 21448903
[TBL] [Abstract][Full Text] [Related]
9. Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.
Roda O; Ortiz-Zapater E; Martínez-Bosch N; Gutiérrez-Gallego R; Vila-Perelló M; Ampurdanés C; Gabius HJ; André S; Andreu D; Real FX; Navarro P
Gastroenterology; 2009 Apr; 136(4):1379-90, e1-5. PubMed ID: 19171142
[TBL] [Abstract][Full Text] [Related]
10. Phenotypical changes of a human pancreatic adenocarcinoma cell line after selection on laminin-1/nidogen (LM/Ng) substratum.
Paddenberg R; Flocke K; Elsässer HP; Lesch G; Heidtmann HH; Mannherz HG
Eur J Cell Biol; 1998 Aug; 76(4):251-64. PubMed ID: 9765055
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia inducible factor 1α down regulates cell surface expression of α1,2-fucosylated glycans in human pancreatic adenocarcinoma cells.
Belo AI; van Vliet SJ; Maus A; Laan LC; Nauta TD; Koolwijk P; Tefsen B; van Die I
FEBS Lett; 2015 Aug; 589(18):2359-66. PubMed ID: 26232512
[TBL] [Abstract][Full Text] [Related]
12. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.
Wu MH; Hong TM; Cheng HW; Pan SH; Liang YR; Hong HC; Chiang WF; Wong TY; Shieh DB; Shiau AL; Jin YT; Chen YL
Mol Cancer Res; 2009 Mar; 7(3):311-8. PubMed ID: 19276182
[TBL] [Abstract][Full Text] [Related]
13. Galectin-8 promotes migration and proliferation and prevents apoptosis in U87 glioblastoma cells.
Metz C; Döger R; Riquelme E; Cortés P; Holmes C; Shaughnessy R; Oyanadel C; Grabowski C; González A; Soza A
Biol Res; 2016 Jul; 49(1):33. PubMed ID: 27459991
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of a new highly metastatic cell line PaTu 8902 from a primary human pancreatic adenocarcinoma.
Elsässer HP; Lehr U; Agricola B; Kern HF
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(4):201-7. PubMed ID: 8287116
[TBL] [Abstract][Full Text] [Related]
15. Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling.
Song S; Ji B; Ramachandran V; Wang H; Hafley M; Logsdon C; Bresalier RS
PLoS One; 2012; 7(8):e42699. PubMed ID: 22900040
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Analgesics on the Migration of Pancreatic Cancer Cells.
Malsy M; Hackl C; Graf B; Bitzinger D; Bundscherer A
In Vivo; 2022; 36(2):576-581. PubMed ID: 35241509
[TBL] [Abstract][Full Text] [Related]
17. Profiling of different pancreatic cancer cells used as models for metastatic behaviour shows large variation in their N-glycosylation.
Holst S; Belo AI; Giovannetti E; van Die I; Wuhrer M
Sci Rep; 2017 Nov; 7(1):16623. PubMed ID: 29192278
[TBL] [Abstract][Full Text] [Related]
18. RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways.
Zhang L; Wang P; Qin Y; Cong Q; Shao C; Du Z; Ni X; Li P; Ding K
Oncogene; 2017 Mar; 36(9):1297-1308. PubMed ID: 27617577
[TBL] [Abstract][Full Text] [Related]
19. Galectin-4 functions as a tumor suppressor of human colorectal cancer.
Satelli A; Rao PS; Thirumala S; Rao US
Int J Cancer; 2011 Aug; 129(4):799-809. PubMed ID: 21064109
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer.
Berberat PO; Friess H; Wang L; Zhu Z; Bley T; Frigeri L; Zimmermann A; Büchler MW
J Histochem Cytochem; 2001 Apr; 49(4):539-49. PubMed ID: 11259457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
